A Novel Risk Calculator Predicts 90-Day Readmission Following Total Joint Arthroplasty

被引:44
|
作者
Goltz, Daniel E. [1 ,2 ]
Ryan, Sean P. [1 ,2 ]
Hopkins, Thomas J. [1 ,3 ]
Howell, Claire B. [1 ,4 ]
Attarian, David E. [1 ,2 ]
Bolognesi, Michael P. [1 ,2 ]
Seyler, Thorsten M. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Durham, NC 27708 USA
[2] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27708 USA
[3] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Performance Serv, Durham, NC 27708 USA
来源
关键词
TOTAL KNEE ARTHROPLASTY; POST-ACUTE CARE; TOTAL HIP; UNPLANNED READMISSION; AMERICAN-COLLEGE; COMPLICATIONS; RATES; PATIENT; IMPACT; COST;
D O I
10.2106/JBJS.18.00843
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: A reliable prediction tool for 90-day adverse events not only would provide patients with valuable estimates of their individual risk perioperatively, but would also give health-care systems a method to enable them to anticipate and potentially mitigate postoperative complications. Predictive accuracy, however, has been challenging to achieve. We hypothesized that a broad range of patient and procedure characteristics could adequately predict 90-day readmission after total joint arthroplasty (TJA). Methods: The electronic medical records on 10,155 primary unilateral total hip (4,585, 45%) and knee (5,570, 55%) arthroplasties performed at a single institution from June 2013 to January 2018 were retrospectively reviewed. In addition to 90-day readmission status, >50 candidate predictor variables were extracted from these records with use of structured query language (SQL). These variables included a wide variety of preoperative demographic/social factors, intraoperative metrics, postoperative laboratory results, and the 30 standardized Elixhauser comorbidity variables. The patient cohort was randomly divided into derivation (80%) and validation (20%) cohorts, and backward stepwise elimination identified important factors for subsequent inclusion in a multivariable logistic regression model. Results: Overall, subsequent 90-day readmission was recorded for 503 cases (5.0%), and parameter selection identified 17 variables for inclusion in a multivariable logistic regression model on the basis of their predictive ability. These included 5 preoperative parameters (American Society of Anesthesiologists [ASA] score, age, operatively treated joint, insurance type, and smoking status), duration of surgery, 2 postoperative laboratory results (hemoglobin and blood-urea nitrogen [BUN] level), and 9 Elixhauser comorbidities. The regression model demonstrated adequate predictive discrimination for 90-day readmission after TJA (area under the curve [AUC]: 0.7047) and was incorporated into static and dynamic nomograms for interactive visualization of patient risk in a clinical or administrative setting. Conclusions: A novel risk calculator incorporating a broad range of patient factors adequately predicts the likelihood of 90-day readmission following TJA. Identifying at-risk patients will allow providers to anticipate adverse outcomes and modulate postoperative care accordingly prior to discharge.
引用
收藏
页码:547 / 556
页数:10
相关论文
共 50 条
  • [31] Association Between Same-Day Discharge Total Joint Arthroplasty and Risk of 90-Day Adverse Events in Patients with ASA Classification of ≥3
    Reddy, Nithin C.
    Prentice, Heather A.
    Paxton, Elizabeth W.
    Hinman, Adrian D.
    Lin, Abraham G.
    Navarro, Ronald A.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2021, 103 (21): : 2032 - 2044
  • [32] A Novel Approach To Reducing 90-Day Readmission Rates For Patients With AeCOPD
    Kirkpatrick, D. P.
    Wells, J. M.
    Bhatt, S. P.
    Tucker, R.
    Leach, L.
    Dransfield, M. T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [33] RISK FACTORS ASSOCIATED WITH 90-DAY READMISSION AFTER PANCREATIC RESECTION
    Roth, Kelly
    Khan, Amir A.
    Scaife, Steven
    Ganai, Sabha
    GASTROENTEROLOGY, 2018, 154 (06) : S1310 - S1310
  • [34] 90-day readmission risk, but not in-hospital mortality is lower in female patients who undergo elective primary total hip arthroplasty for osteoarthritis
    Chandrupatla, Sumanth R.
    Singh, Jasvinder A.
    CLINICAL RHEUMATOLOGY, 2024, 43 (12) : 4005 - 4008
  • [35] Intravenous vancomycin use at discharge and 90-day risk of readmission or death
    Eiffert, Samantha
    Kinlaw, Alan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 259 - 259
  • [36] Risk and Cost of 90-Day Complications in Morbidly and Superobese Patients After Total Knee Arthroplasty
    Meller, Menachem M.
    Toossi, Nader
    Johanson, Norman A.
    Gonzalez, Mark H.
    Son, Min-Sun
    Lau, Edmund C.
    JOURNAL OF ARTHROPLASTY, 2016, 31 (10): : 2091 - 2098
  • [37] Hospital, Patient, and Clinical Factors Influence 30-and 90-Day Readmission After Primary Total Hip Arthroplasty
    Kurtz, Steven M.
    Lau, Edmund C.
    Ong, Kevin L.
    Adler, Edward M.
    Kolisek, Frank R.
    Manley, Michael T.
    JOURNAL OF ARTHROPLASTY, 2016, 31 (10): : 2130 - 2138
  • [38] Race Is Associated with Discharge Disposition after Total Knee Arthroplasty (TKA), Which Is Associated with 90-Day Readmission Rate
    Singh, Jasvinder A.
    Kallan, Michael
    Ibrahim, Said
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [39] Risk Factors for 30-day and 90-day Readmission After Lumbar Decompression
    Canseco, Jose A.
    Karamian, Brian A.
    Minetos, Paul D.
    Paziuk, Taylor M.
    Gabay, Alyssa
    Reyes, Ariana A.
    Bechay, Joseph
    Xiao, Kevin B.
    Nourie, Blake O.
    Kaye, I. David
    Woods, Barrett I.
    Rihn, Jeffrey A.
    Kurd, Mark F.
    Anderson, D. Greg
    Hilibrand, Alan S.
    Kepler, Christopher K.
    Schroeder, Gregory D.
    Vaccaro, Alexander R.
    SPINE, 2022, 47 (09) : 672 - 679
  • [40] Total Knee Arthroplasty: Variables Affecting 90-day Overall Reimbursement
    Halperin, Scott J.
    Dhodapkar, Meera M.
    Radford, Zachary J.
    Li, Mengnai
    Rubin, Lee E.
    Grauer, Jonathan N.
    JOURNAL OF ARTHROPLASTY, 2023, 38 (11): : 2259 - 2263